79 related articles for article (PubMed ID: 26458838)
1. Polycistronic Herpesvirus Amplicon Vectors for Veterinary Vaccine Development.
Meier AF; Laimbacher AS; Ackermann M
Methods Mol Biol; 2016; 1349():201-24. PubMed ID: 26458838
[TBL] [Abstract][Full Text] [Related]
2. HSV-1 amplicon vectors as genetic vaccines.
Laimbacher AS; Fraefel C
Methods Mol Biol; 2014; 1144():99-115. PubMed ID: 24671679
[TBL] [Abstract][Full Text] [Related]
3. Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.
Meier AF; Suter M; Schraner EM; Humbel BM; Tobler K; Ackermann M; Laimbacher AS
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212334
[TBL] [Abstract][Full Text] [Related]
4. HSV-1 Amplicon Vectors as Genetic Vaccines.
Meier AF; Laimbacher AS
Methods Mol Biol; 2020; 2060():111-130. PubMed ID: 31617175
[TBL] [Abstract][Full Text] [Related]
5. Virus-like particles: promising platforms with characteristics of DIVA for veterinary vaccine design.
Liu F; Wu X; Li L; Ge S; Liu Z; Wang Z
Comp Immunol Microbiol Infect Dis; 2013 Jul; 36(4):343-52. PubMed ID: 23561290
[TBL] [Abstract][Full Text] [Related]
6. HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization.
D'Antuono A; Laimbacher AS; La Torre J; Tribulatti V; Romanutti C; Zamorano P; Quattrocchi V; Schraner EM; Ackermann M; Fraefel C; Mattion N
Vaccine; 2010 Oct; 28(46):7363-72. PubMed ID: 20851082
[TBL] [Abstract][Full Text] [Related]
7. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
8. Strategies for design and application of enteric viral vaccines.
Chattha KS; Roth JA; Saif LJ
Annu Rev Anim Biosci; 2015; 3():375-95. PubMed ID: 25387111
[TBL] [Abstract][Full Text] [Related]
9. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
10. The pentavalent rotavirus vaccine, RotaTeq.
Matson DO
Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
[TBL] [Abstract][Full Text] [Related]
11. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
Brake DA; McIlhaney M; Miller T; Christianson K; Keene A; Lohnas G; Purcell C; Neilan J; Schutta C; Barrera J; Burrage T; Brough DE; Butman BT
Dev Biol (Basel); 2012; 134():123-33. PubMed ID: 22888605
[TBL] [Abstract][Full Text] [Related]
12. [Experiences obtained thus far in the immunoprophylaxis of rotavirus infections in calves].
Heinrich HW; Liebermann H; Hahnefeld H; Schirrmeier H
Arch Exp Veterinarmed; 1983; 37(2):317-22. PubMed ID: 6307204
[No Abstract] [Full Text] [Related]
13. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
[TBL] [Abstract][Full Text] [Related]
14. Immune response of pregnant cows to bovine rotavirus immunization.
Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
[TBL] [Abstract][Full Text] [Related]
15. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
16. Studies with an inactivated pheasant rotavirus vaccine.
Gough RE; Cox WJ; Davis C
Vet Rec; 1999 Apr; 144(15):423-4. PubMed ID: 10331233
[No Abstract] [Full Text] [Related]
17. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization of mice with VP2 DNA of human rotavirus a induces cellular and humoral immunity.
Pourasgari F; Ahmadian S; Hassan ZM; Mahdavi M; Salmanian AH; Sarbolouki MN; Pothier P
Acta Virol; 2008; 52(4):225-9. PubMed ID: 19143478
[TBL] [Abstract][Full Text] [Related]
19. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.
McNeal MM; Broome RL; Ward RL
Virology; 1994 Nov; 204(2):642-50. PubMed ID: 7941332
[TBL] [Abstract][Full Text] [Related]
20. Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.
Avakian AP; Poston RM; Kong FK; Van Kampen KR; Tang DC
Expert Rev Vaccines; 2007 Jun; 6(3):457-65. PubMed ID: 17542759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
